Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells

Mol Microbiol. 1993 Jan;7(2):323-7. doi: 10.1111/j.1365-2958.1993.tb01123.x.

Abstract

Bafilomycin A1, a specific inhibitor of the vacuolar-type H(+)-ATPase, responsible for acidification of intracellular compartments, prevents the vacuolization of Hela cells induced by H. pylori, with an inhibitory concentration giving 50% of maximal (ID50) of 4 nM. Bafilomycin A1 is also very efficient in restoring vacuolated cells to a normal appearance. The vacuolating activity of Helicobacter pylori is not inhibited by a series of specific inhibitors of vacuolar H(+)-ATPases. These findings indicate that a transmembrane pH gradient is needed for the formation and growth of vacuoles caused by the bacterium and that this pH gradient is due to the activity of a vacuolar ATPase proton pump of HeLa cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • HeLa Cells / drug effects
  • HeLa Cells / microbiology*
  • HeLa Cells / ultrastructure
  • Helicobacter pylori / pathogenicity
  • Helicobacter pylori / physiology*
  • Humans
  • Hydrogen-Ion Concentration
  • Intracellular Fluid / chemistry
  • Macrolides*
  • Proton Pumps / drug effects*
  • Proton-Translocating ATPases / antagonists & inhibitors*
  • Vacuoles / enzymology*
  • Virulence

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • Proton Pumps
  • bafilomycin A1
  • Proton-Translocating ATPases